Digital as the Differentiator for Biopharma and Medtech

Digital as the Differentiator for Biopharma and Medtech

With the Inflation Reduction Act now on the books, the U.S. Centers for Medicare & Medicaid Services (CMS) will begin negotiating drug prices with the pharmaceutical industry. That, combined with other headwinds such as increased competition from me-too drugs, and ever-present pricing pressure from payers, means that pharma players now more than ever need a new and powerful tool to differentiate their products. We believe the next decade of transformation is digital.
Learning from the auto industry Almost every industry has had to confront a fundamental existential question: What is our product? Consider the automotive industry, which once was largely about hardware…

Continue Reading
HHS Aims To Reduce Prescription Drug Costs Through 3 New Models

HHS Aims To Reduce Prescription Drug Costs Through 3 New Models

The U.S. Department of Health & Human Services (HHS) unveiled three new models Tuesday that will be tested by the CMS Innovation Center and aim to lower prescription drug costs. The models include access to $2 generic drugs.
The news is in response to President Joe Biden’s executive order issued in October, which directed HHS to find ways to lower prescription drug costs and improve access to drug therapies for those enrolled in Medicare and Medicaid health plans. The models are meant to build on the Inflation Reduction Act of 2022, which includes allowing Medicare to negotiate lower prescription drug prices for…

Continue Reading
Rising Costs Are Keeping Healthcare CFOs Up a Night — Can Data Help?

Rising Costs Are Keeping Healthcare CFOs Up a Night — Can Data Help?

The increasing costs of labor and supplies are the top issues keeping healthcare CFOs up at night, according to a new report released by Syntellis, a provider of performance management software. To effectively address these concerns, healthcare providers must ensure they have access to data-driven analytics software that can help them make important decisions — such as how to effectively manage their existing workforce and where to shift care delivery models — the report said.
Syntellis surveyed more than 200 U.S. healthcare finance professionals who work at hospitals, health systems and integrated delivery networks. These professionals agreed that last year was a…

Continue Reading
What Are The Challenges Expected to be Faced by Healthcare in 2023?

What Are The Challenges Expected to be Faced by Healthcare in 2023?

Healthcare is an ever-evolving industry, and as we move into 2023, there are a number of challenges are expected to arise.
The economy is already headed toward recession, and experts have made it quite clear that this year will be the most difficult one for the global economy.
Image credit: BBC
Inflation in the US is already touching its highest pick ever and Eventually, this will have an impact on the healthcare sector as well. Since healthcare is one of the major economic contributors.
Therefore, it is clear that healthcare would experience some significant difficulties in 2023.
However, healthcare providers must be ready…

Continue Reading